News
Mutua Madrileña Foundation funds a research project on personalized treatments in lung cancer
The Mutua Madrileña Foundation in its XI Call for Research Grants, has selected a project aimed at personalizing the treatment of lung cancer led by the team leader of the ICO-IDIBELL chemoresistance group, Alberto Villanueva. The project is based on the personalization of cancer treatments for non-small cell lung (NSCLC) by the generation of mouse […]
Xavier Bosch, among the most important scientists of the world
The agency Thomson Reuters has published the Highly Cited Researchers, a list of the most recognized in the world based on the number of citations received their education researchers. Among the 3,000 researchers from the 47 most influential disciplines are Spanish. The section on clinical medicine, meanwhile, includes 402 researchers worldwide, of which 7 are […]
Seven students will live summer at IDIBELL
Upon evaluation of the received applications, the Scientific Direction announces the admittance to the Summer Training Program 2014 We congratulate the candidates and their hosting researchers, and wish them a fruitful formative stay in IDIBELL.
The aecc funds a research project on lung cancer participated by IDIBELL
The Spanish Association against Cancer (AECC) has awarded aid 1 million two hundred thousand euros to identify new therapeutic targets and prognostic markers in lung tumors poorly characterized. The project has duration of five years. Lung cancer is one of the tumors having higher mortality rates worldwide. Only in Spain each year about 20,000 people […]
Researchers discover that synaptic levels of clathrin protein are important for neuronal plasticity
Chemical synapses and synaptic vesicular transmission cycle The dogma of the clathrin Article’s reference
Effective drugs for Parkinson’s reduce symptoms of Rett syndrome in mice
Second leading cause of mental retardation in females Article reference Article reference Neuropsychopharmacology
ICO-IDIBELL researchers collaborate in raising funds for cancer research
Under the slogan “Loud and clear against cancer: Research” on 5 June, the Spanish Association Against Cancer Barcelona (AECC) hit the streets to raise funds with a clear objective: financing research against cancer. The aecc marquee located at Barcelona downtown became a laboratory where ICO-IDIBELL researchers showed people how day a day cancer research is, […]
Identified a key molecular pathway in the acquisition of resistance to therapy in certain breast tumors
Estrogens are essential female hormones that perform many basic functions in the body. However, on some occasions it may also cause or contribute to the growth of some cancers, including breast, because it stimulates the growth and division of tumor cells. The estrogens-responsive tumors are known as “positive for the estrogens receptor” and it is […]